Combination use of paclitaxel and avastin enhances treatment effect for the NSCLC patients with malignant pleural effusion

The current study is conducted to investigate efficacy of the chemotherapy drug paclitaxel in combination with Avastin (Roche Diagnostics GmbH., Mannheim, Germany) (antiangiogenic agent) in treatment of malignant pleural effusions (MPEs). Twenty-four patients with non–small cell lung cancer were ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Nan, Li, Fang, Li, Xiaosong, Kang, Huanrong, Zhao, Hui, Du, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134869/
https://www.ncbi.nlm.nih.gov/pubmed/27893676
http://dx.doi.org/10.1097/MD.0000000000005392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134869/
https://www.ncbi.nlm.nih.gov/pubmed/27893676
http://dx.doi.org/10.1097/MD.0000000000005392

Ejemplares similares